Comparing normal saline vs ringer's lactate for sepsis fluid treatment
Part of Infections clinical trials.
This trial tests two common fluids given in the emergency department for sepsis patients to see which is better. If you have sepsis (a severe infection) and need fluids, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have sepsis or suspected sepsis from an infection.
- You or your family can agree to the study in writing.
- You are not pregnant.
- You do not need a breathing tube or CPR right now.
- You do not have other causes of fluid loss like burns or bleeding.
- You do not have severe heart or kidney problems that limit fluid types.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new way of measuring how much fluid leaks from your blood vessels during severe infection (septic shock). The goal is to help doctors decide how much fluid to give, which may improve recovery and prevent complications.
This trial tests whether a fluid called Gelaspan (a gelatin-based IV fluid) is better for treating sepsis patients who need emergency abdominal surgery than standard crystalloid fluids. It checks if you have a belly infection and high lactate levels, and you must not have serious heart, lung, or kidney problems.
This study uses heart ultrasound (echocardiography) to help doctors decide how much fluid to give patients with sepsis, a serious blood infection. The goal is to improve how well the heart pumps and help patients recover better.
This study tests a personalized approach to giving fluids to patients with sepsis, a serious infection that can cause low blood pressure. The goal is to see if individualized fluid resuscitation improves outcomes compared to standard care.
This trial tests a personalized approach to giving IV fluids to patients with sepsis in the emergency department. It uses a device to monitor your heart and blood flow to help doctors decide how much fluid you need, which may improve recovery.
This Phase 3 trial tests whether starting a medicine called norepinephrine early can improve outcomes for adults with sepsis (a serious body-wide response to infection) and low blood pressure. You might be considered if you’re very early in hospital care and meet specific blood pressure and lactate tests.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.